Skip to main content
Year archive

EMVISION MEDICAL DEVICES LTD — 2020 filings

All 60 regulatory filings released by EMVISION MEDICAL DEVICES LTD (EMV) in 2020, sourced directly from the official regulator.

60 Filings
2020 Period
2020 filings (60)
Filing Released Lang
Change of Principal Place of Business 2 pages 170.7KB
Regulatory Filings
2020-12-20 English
Australian Stroke Alliance & FDA Update 2 pages 172.4KB
Regulatory Filings
2020-12-20 English
Appendix 2A - Exercise of Options 15 pages 302.4KB
Capital/Financing Update
2020-12-16 English
Ceasing to be a substantial holder 2 pages 123.7KB
Major Shareholding Notification
2020-12-16 English
Substantial Shareholder Update 2 pages 175.0KB
Major Shareholding Notification
2020-12-16 English
Prof Stuart Crozier Appointed as Chief Scientific Officer 2 pages 176.2KB
Board/Management Information
2020-12-16 English
Change of Director's Interest Notice - Correction 4 pages 318.4KB
Director's Dealing
2020-12-13 English
Appendix 2A - Release of Restricted Securities 15 pages 301.6KB
Regulatory Filings
2020-12-13 English
Appendix 2A - Exercise of Options 15 pages 302.4KB
Capital/Financing Update
2020-12-13 English
EMVision Receives $1.28M R&D Tax Incentive Rebate for FY20 2 pages 193.9KB
Regulatory Filings
2020-12-13 English
Release of Restricted Securities from Escrow 1 page
Regulatory Filings
2020-12-06 English
Appendix 3G - Issue of Options 16 pages 447.7KB
Share Issue/Capital Change
2020-12-06 English
Change of Director's Interest Notice 3 pages 219.4KB
Director's Dealing
2020-12-06 English
Change of Director's Interest Notice 3 pages 217.3KB
Director's Dealing
2020-12-06 English
Change of Director's Interest Notice 3 pages 182.8KB
Director's Dealing
2020-12-02 English
AGM Chairman's Address & CEO Presentation 15 pages 2.0MB
AGM Information
2020-11-25 English
Results of Annual General Meeting 2 pages 158.7KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-25 English
Investor Presentation - Bell Potter Healthcare Conference 12 pages 2.3MB
Investor Presentation
2020-11-24 English
Appendix 4C - quarterly 12 pages 278.0KB
Interim / Quarterly Report
2020-10-29 English
EMVision Reports Very Encouraging Pilot Clinical Trial Data 7 pages 1.0MB
Regulatory Filings
2020-10-27 English
Notice of Annual General Meeting/Proxy Form 38 pages 742.3KB
AGM Information
2020-10-26 English
Appendix 3G - Issue of Options 16 pages 458.5KB
Share Issue/Capital Change
2020-10-22 English
Date of AGM & Closing Date for Director Nominations 2 pages 144.6KB
AGM Information
2020-10-07 English
Change of Director's Interest Notice 3 pages 182.5KB
Director's Dealing
2020-10-01 English
Dr Philip Dubois Appointed as Non-Executive Director 3 pages 178.7KB
Board/Management Information
2020-09-28 English
Initial Director's Interest Notice 2 pages 175.9KB
Director's Dealing
2020-09-28 English
Final Director's Interest Notice 2 pages 291.7KB
Director's Dealing
2020-09-28 English
Appendix 3G - Issue of Options 16 pages 451.6KB
Share Issue/Capital Change
2020-09-28 English
EMVision Completes 30 Patient Enrolment 3 pages 158.8KB
Regulatory Filings
2020-09-07 English
Appendix 4E & Annual Report 30 June 2020 47 pages 4.3MB
Regulatory Filings
2020-08-26 English
Appendix 4G & Corporate Governance Statement 25 pages 534.3KB
Governance Information
2020-08-26 English
Advance QLD Industry Fellowship Win 2 pages 178.5KB
Regulatory Filings
2020-08-24 English
EMVision Appoints Head of Program Management 2 pages 147.7KB
Board/Management Information
2020-08-11 English
Appendix 4C- quarterly - Additional Information 3 pages 189.8KB
Interim / Quarterly Report
2020-08-05 English
Change in substantial holding 3 pages 186.2KB
Major Shareholding Notification
2020-08-04 English
Auditor Resignation & Appointment 2 pages 167.5KB
Audit Report / Information
2020-08-03 English
Change in substantial holding 3 pages 182.9KB
Major Shareholding Notification
2020-07-30 English
Ceasing to be a substantial holder 2 pages 226.6KB
Regulatory Filings
2020-07-30 English
Appendix 2A & Cleansing Notice - Placement 16 pages 418.6KB
Capital/Financing Update
2020-07-29 English
Proposed issue of Securities - EMV 5 pages 28.1KB
Capital/Financing Update
2020-07-23 English
EMVision Receives Binding Commitments for $9M Placement 2 pages 171.3KB
Capital/Financing Update
2020-07-23 English
Appendix 4C - quarterly 9 pages 285.7KB
Interim / Quarterly Report
2020-07-21 English
Encouraging Haemorrhagic Images with Classification 5 pages 793.6KB
Regulatory Filings
2020-07-21 English
Trading Halt 2 pages 404.0KB
Regulatory Filings
2020-07-21 English
Appendix 2A & Cleansing Notice - Exercise of Options 16 pages 417.9KB
Capital/Financing Update
2020-07-02 English
Appendix 3G - Issue of Options 16 pages 452.9KB
Share Issue/Capital Change
2020-07-02 English
Investor Presentation 17 pages 2.6MB
Investor Presentation
2020-06-24 English
Appendix 2A & Cleansing Notice 16 pages 425.9KB
Share Issue/Capital Change
2020-06-15 English
Release of Restricted Securities from Escrow 1 page
Capital/Financing Update
2020-06-08 English
Clinical Trial Enrolment Recommences 2 pages 165.8KB
Regulatory Filings
2020-05-13 English
Dr Ron Weinberger Appointed Managing Director 2 pages 155.2KB
Board/Management Information
2020-05-05 English
Initial Director's Interest Notice 2 pages 162.4KB
Director's Dealing
2020-05-05 English
Appendix 4C - quarterly 9 pages 249.5KB
Interim / Quarterly Report
2020-04-29 English
Promising First Stroke Patient Images From Clinical Trial 4 pages 496.7KB
Regulatory Filings
2020-04-20 English
Clinical Trial Update 2 pages 144.2KB
Capital/Financing Update
2020-04-01 English
Clinical Trial Update 2 pages 147.8KB
Regulatory Filings
2020-03-24 English
Half Year Report & CEO Update 19 pages 550.8KB
Interim / Quarterly Report
2020-02-26 English
Advance QLD Industry Fellowship Wins 2 pages 177.7KB
Regulatory Filings
2020-02-19 English
Appendix 4C - quarterly 9 pages 343.6KB
Interim / Quarterly Report
2020-01-29 English
EMVision Commences Clinical Trial 2 pages 165.8KB
Regulatory Filings
2020-01-28 English